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The influence of duplex stabilizing oligonucleotide-effector (oligonucleotide, carrying N-(2-hydroxyethyl)phenazinium residues on both ends), on 
selectivity of site-directed modification of E. cofi 16 S rRNA (1542 nucleotides in length) under the conditions of its secondary structure stability 
was studied. The constant of cooperative binding of the reagent and the oligonucleotide-effector with 16 S rRNA was determined. The accuracy 
of modification was shown to double in the presence of 50 PM effector at 5 PM concentration of the reagent. 
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1. INTRODUCTION 
One of the key problems of the hybridization arrest 
of translation by antisense oligonucleotides both in 
vitro [1,2] and in vivo [3] is to find the ways to enhance 
the accuracy of directed influence of these 
oligonucleotides on the target. 
Earlier site-directed modification of E. coli 16 S 
rRNA with 4-[N-methyl-N-(2-chloroethyl)amino]- 
benzylidene derivatives of oligodeoxynucleotides re- 
presenting reactive analogs of antisense oligonucleo- 
tides was studied [4-71. 16 S rRNA was used as a 
model of high molecular weight target with complex 
spatial structure. It was found that, under the condi- 
tions of 16 S rRNA secondary structure stability (ionic 
strength 0.37 M) and at reagents concentrations within 
the range of 5-30/cM [4], not only target sites were 
alkylated. Along with them, other sequences undergo 
modification, forming imperfect duplexes (duplexes 
with mismatches and dangling ends) with the reagent. 
The selectivity of modification could be improved, 
therefore, by excluding these imperfect complexes from 
the sphere of reaction. 
Recently a principally new method to enhance selec- 
tivity of sequence-specific modification was proposed 
[&lo]. It is based on using oligonucleotide-effector (E) 
carrying N-(2-hydroxyethyl)-phenazinium residues 
working as an intercalator on one or both ends and 
complementary to the nucleic acid sequence adjacent o 
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the reagent (X) binding site [lo]. The accuracy of 
modification was improved due to the cooperativity of 
binding of the X and E with the target. This resulted in 
lengthening of the double-helix region formed by the 
reagent and effector with nucleic acid. 
This study is the first attempt to analyze the use of 
the oligonucleotide-effector for enhancement of selec- 
tivity of site-directed alkylation of high molecular 
weight target (16 S rRNA). The alkylating agent 
(reagent or X) was 2’ ,3 ’ -0[4-N-methyl-N-(2-chloro- 
ethyl)amino]benzylidene derivative of d(pTTTGCTC- 
CCC)rA. The effector was 3 ’ ,5 ’ -diphenazinium 
derivative of p(dTAATCCTG)p. 
2. MATERIALS AND METHODS 
RNase H was kindly donated by Dr N.V. Chichkova; plasmid pKK 
3535 was a gift of Dr H.F. Noller; T4 RNA-ligase, RNase A, restric- 
tion enzymes Xbal, BarnHI, MspI, HaeIII, AM were purchased 
from NPO ‘Ferment’ (USSR); other reagents were from Fluka, 
Merck, Sigma and Serva. 
Synthesis of the reagent (X), having either “P-1abelled 5 ‘-end of 
the oligonucleotide part or [‘4C]-labelled reactive fragment, was per- 
formed according to the method described in [ll]. 
Synthesis of E: Phn-p(dTAATCCTG)p-Phn was carried out in ac- 
cordance with [8]. 
Isolation and preparation of 16 S rRNA for site-directed aikylation 
by such type of reagents are described in [5]. Modification of 16 S 
rRNA by X was performed in TMKlso buffer (50 mM Tris-HCl, pH 
7.4; 20 mM MgClz; 0.35 M KCl) at RNA concentration of 0.5 fiM 
for 30.3 h at 20°C. 50% of X was converted into ethyleneimmonium 
cation (the reactive intermediate) under these conditions. The initial 
concentration of the reagent being constant, the concentration of E 
varying. The reaction mixture contained 5 nmol of 16 S rRNA and 
was 10 ~1 in volume. The reaction was terminated by precipitation of 
RNA by 10 vols of 2% LiC104 in acetone. The alkylated 16 S rRNA 
was separated from the unreacted reagent by denaturing PAAG 6% 
electrophoresis (20 x 30 x 0.02 cm). The extent of modification was 
determined from the amount of the “P-label in the 16 S rRNA band. 
The assays of selectivity of modification. 16 S rRNA was alkylated 
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by “C-labelled X on preparative scale (150 pmol of RNA). The 
covalent adducts 16 S rRNA-X (the products of sequence specific 
modification of 16 S rRNA by X) were isolated according to [6]. 
RNase H hydrolysis of RNA-chain within the covalent adducts as 
well as identification of alkylated sites by blot-hybridization of RNA- 
fragments (obtained by RNase H hydrolysis of the covalent adducts) 
to the restriction fragments of pKK 3535 plasmid [12], are described 
in detail in [6,7]. 
3. RESULTS AND DISCUSSION 
16 S rRNA E. coli was chosen as a model to test the 
oligonucleotide-effector (E) ability to improve the ac- 
curacy of sequence-specific modification of highly 
structured target. The 3 ’ ,5 ’ -diphenazinium derivative 
of p(dTAATCCTG)p (E) was complementary to 16 S 
rRNA sequence 782-789 which was adjacent to the 
target sequence 771-781. Fig. 1 shows the structure of 
16 S rRNA fragment including the sequences com- 
plementary to the X and E. 
The nucleic acids modification by reactive 
oligonucleotide derivatives in the presence of E can be 
described by the following kinetic scheme: 
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Fig. 1. Structure of 16 S RNA domain comprising a full 
complementary copy of the reagent (X) and oligonucleotide-effector 
(E). 
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where P is target nucleic acid; X is reagent; E is 
oligonucleotide-effector; I is reactive ethyleneim- 
monium cation formed at the limiting step of the reac- 
tion; R is product of reagent hydrolysis in solution; PZ 
is the product of modification; PX, PE, PI, PR, PXE, 
PRE, PZE are complexes formed within this system; 
k,, kl, kz, kI, k-1 are the reaction rate constants hown 
in the scheme. Presumably, target P has a number of 
binding sites n for X (one of them is fully matched and 
others are imperfect) and a single site for E binding 
(this site is adjacent to the target region forming fully 
matched duplex with X). The rise of X concentration 
increases the amount of all n PX complexes that leads 
to the non-specific modification of the target; while the 
increase in E concentration should stimulate the forma- 
tion of PXE complex only. Due to cooperative nature 
of X binding in PXE complex, the formation of PX 
complexes is less favourable and the level of modifica- 
tion in imperfect complexes hould be lower, than that 
without effector. 
Fig. 2 represents the extent of 16 S rRNA modifica- 
tion by X versus concentration of the E. We observed 
a rather small range of concentrations (Fig. 2, curves 
l-5): 20-100 PM, at which the increase of E concentra- 
tion led to a significant increase in the extent of 
modification (a,,). The largest increase of a0 (up to 0.32 
and 0.40) was observed at X concentrations 0.5 /cM and 
1.5 PM, respectively, in the presence of E (Fig. 2, 
curves 1, 2). In the absence of E at the same X concen- 
trations, crO was equal to 0.06 and 0.10, respectively. 
When X concentration was increased up to 5 gM in the 
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Fig. 2. The extent of 16 S rRNA modification (LYO) by X versus 
concentration of effector (e,) at 2O’C; 16 S rRNA concentration was 
equal to 0.5 pM, X concentrations were 1, 0.5 PM; 2, 1.5 PM; 3, 
2.5 PM; 4, 4.0 PM; 5, 5.0rM. 
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presence of E, the increase of cy,, on the plateau reached 
0.60 (Fig. 2, curve 5). 
Based on the data of 16 S rRNA modification at 
20°C in the presence of E, we calculated the constant 
of cooperative binding of X and E with RNA target 
(KxE). KXE was equal to (8.4 + 3.5) X 10” M-*. KXE 
can be expressed as KXE = a - KX * KE, where a is 
cooperativity factor; KX and KE are binding constants 
of X and E with 16 S rRNA. KX value was determined 
in [4]. However, since KE is unknown we could not 
calculate cooperativity factor a. 
Earlier, it was shown that X could bind 16 S rRNA 
at 12 sites, forming (besides 771-781) imperfect 
duplexes with the reagent. Among 12 sites found for X, 
3 (663-673, 442-452, 883-893) could form imperfect 
complexes which were of similar stability as the perfect 
one with site 771-781 [7]. In the separate experiments 
we assayed selectivity of 16 S rRNA modification in the 
presence and absence of E (see Table I). The measures 
of selectivity of sequence specific modification were 
chosen to be (i) relative extent of modification onto the 
selected site of 16 S rRNA (771-781; W/CUO; see Table 
I), and (ii) relative extent of modification within 3 most 
stable imperfect complexes and within the selected site 
(az/cro). The resulting changes of selectivity of 16 S 
rRNA modification in the presence of E are given in 
Table I. It is seen that the changing of 16 S rRNA 
modification extent in the presence of E is due to the 
increase of modification extent at the selected site. In 
the absence of E, the modification at 771-781 amounts 
to about 20% of the overall amount whereas in the 
presence of E this value is more than doubled. 
So, the attempts to improve accuracy of sequence- 
specific alkylation of high molecular weight RNA by 
using oligonucleotide-effecters carrying N-(2-hydroxy- 
ethyl)-phenazinium residues eem to be successful. Our 
data show that at a concentration of the reagent in the 
PM range, the application of 50 PM effector concentra- 
tion brings about more than two-fold enhancement of 
selectivity of sequence-specific modification. 
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